Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/15596297

Cancer Lett. 2005 Jan 10 217 1 61-72

Download in:

View as

General Info

PMID
15596297